Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Original Article
V. Perkovic, M.J. Jardine, B. Neal, S. Bompoint, H.J. Heerspink, D.M. Charytan, R. Edwards, R. Agarwal, G. Bakris, S. Bull, C.P. Cannon, G. Capuano, P.-L. Chu, D.d. Zeeuw, T. Greene, A. Levin, C. Pollock, D.C. Wheeler, Y. Yavin, H. Zhang, B. Zinman, G. Meininger, B.M. Brenner, and K.W. Mahaffey
N Engl J Med 2019;380:2295-2306
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, June 13, 2021 - 11:59pm.